Rakhi Kumar serves as the Chief Accounting Officer at ROIVANT SCIENCES LTD, a prominent biopharmaceutical company focused on developing innovative therapies. With an extensive background in finance and accounting, Kumar has been instrumental in steering the company's financial strategies and ensuring compliance with regulatory standards. Prior to joining ROIVANT SCIENCES LTD, Kumar held several high-profile positions in the finance sector, where she honed her expertise in financial reporting, internal controls, and strategic planning. Kumar's career is marked by significant achievements that have contributed to her reputation as a leading figure in corporate finance. She has successfully led multiple financial transformations and system implementations, enhancing operational efficiencies and financial transparency across organizations. Her strategic vision and meticulous attention to detail have been pivotal in driving the financial health and growth of ROIVANT SCIENCES LTD. In her current role, Kumar oversees the company's global accounting operations, ensuring accurate financial reporting and robust internal controls, which are critical for the company's continued success and expansion. As Chief Accounting Officer, Rakhi Kumar plays a crucial role in shaping ROIVANT SCIENCES LTD's financial policies and practices. Her leadership is essential in navigating the complex financial landscape of the biopharmaceutical industry, where innovation and compliance must go hand in hand. Kumar's ability to blend strategic foresight with operational excellence has made her an invaluable asset to the company, fostering a culture of financial integrity and accountability that supports ROIVANT SCIENCES LTD's mission to bring transformative therapies to patients worldwide.